Strides Pharma Science Gets ACCC Approval for Merger of Arrow and Apotex Australia

Strides Pharma Science announced that the Australian Competition and Consumer Commission (ACCC) has approved the merger of generic pharmaceutical companies Arrow and Apotex. In May 2018, Strides Pharma Science and Apotex Inc. announced their intention to merge Arrow Pharmaceuticals and Apotex Australia into a new company. The transaction remains subject to the conclusion of definitive agreements, Board approval and the satisfaction of certain other conditions, including approval from the Australian Foreign Investment Review Board. – Business Standard